Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-04 Sale |
2025-04-07 4:59 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
245 | $3.74 | $916 | 82,739 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:27 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
3,445 | $6.29 | $21,669 | 34,314 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:27 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
11,694 | $6.29 | $73,555 | 82,984 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:26 pm |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
3,587 | $6.29 | $22,562 | 29,272 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:24 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
3,548 | $6.29 | $22,317 | 27,414 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:15 pm |
Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer |
571 | $6.29 | $3,592 | 9,713 (Direct) |
View |
| 2025-03-04 Sale |
2025-03-06 4:13 pm |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
2,793 | $6.29 | $17,568 | 21,047 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 4:17 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
5,914 | $0.63 | $3,726 | 320,714 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-05 4:16 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
4,099 | $0.65 | $2,664 | 1,120,158 (Direct) |
View |
| 2025-01-06 Sale |
2025-01-07 4:03 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
4,055 | $0.783 | $3,175 | 1,124,257 (Direct) |
View |
| 2024-12-04 Sale |
2024-12-05 4:15 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,620 | $0.81 | $2,932 | 1,128,312 (Direct) |
View |
| 2024-11-05 Sale |
2024-11-06 4:06 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,675 | $0.9106 | $3,346 | 1,131,932 (Direct) |
View |
| 2024-10-04 Sale |
2024-10-07 4:44 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,607 | $0.8793 | $3,172 | 1,135,607 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-05 4:28 pm |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
3,971 | $0.7218 | $2,866 | 273,881 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-05 4:26 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,667 | $0.7218 | $2,647 | 1,139,214 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-05 4:24 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
7,050 | $0.7218 | $5,089 | 391,054 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-05 4:13 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
5,356 | $0.7218 | $3,866 | 404,051 (Direct) |
View |
| 2024-08-06 Sale |
2024-08-08 4:31 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,608 | $0.9299 | $3,355 | 1,142,881 (Direct) |
View |
| 2024-07-30 Sale |
2024-07-31 4:14 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
2,883 | $1.06 | $3,056 | 326,628 (Direct) |
View |
| 2024-07-05 Sale |
2024-07-09 4:15 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,616 | $0.851 | $3,077 | 1,146,489 (Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 7:18 pm |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
818,044 | $0.95964 | $785,027 | 0 (Indirect) |
View |
| 2024-06-04 Sale |
2024-06-06 4:03 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
652 | $0.99 | $645 | 398,104 (Direct) |
View |
| 2024-06-04 Sale |
2024-06-06 4:02 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,592 | $0.99 | $3,556 | 1,150,105 (Direct) |
View |
| 2024-05-31 Sale |
2024-06-04 6:51 pm |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
906,178 | $0.97188 | $880,693 | 7,911 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 4:54 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
29,998 | $0 | 57,758 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:52 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
29,998 | $0 | 52,858 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:51 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
28,749 | $0 | 50,128 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:49 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer |
2,799 | $0 | 12,150 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:48 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
60,000 | $0 | 134,678 (Direct) |
View |
| 2025-02-28 Option Award |
2025-03-04 4:46 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
16,749 | $0 | 35,006 (Direct) |
View |
| 2025-01-31 Option Award |
2025-02-03 4:15 pm |
N/A 2035-01-30 |
Karyopharm Therapeutics Inc. | KPTI | Macomber Lori EVP, CFO & Treasurer |
810,000 | $0 | 810,000 (Direct) |
View |
Ownership |
2024-11-22 4:01 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer |
0 | $0 | 140,300 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 5:32 pm |
N/A 2034-05-28 |
Karyopharm Therapeutics Inc. | KPTI | Su Zhen Director |
50,587 | $0 | 50,587 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 5:32 pm |
N/A 2034-05-28 |
Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director |
69,000 | $0 | 69,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 5:32 pm |
N/A 2034-05-28 |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
69,000 | $0 | 69,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 5:32 pm |
N/A 2034-05-28 |
Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director |
69,000 | $0 | 69,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 5:32 pm |
N/A 2034-05-28 |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
69,000 | $0 | 69,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 5:25 pm |
N/A 2034-05-28 |
Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director |
69,000 | $0 | 69,000 (Direct) |
View |
| 2024-05-29 Option Award |
2024-05-30 5:19 pm |
N/A 2034-05-28 |
Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director |
69,000 | $0 | 69,000 (Direct) |
View |